XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Nov. 01, 2025
Nov. 02, 2024
Operating Activities    
Net earnings $ 14,440 $ 102,190
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation 35,081 29,456
Amortization of capitalized software 3,711 3,939
Amortization of intangible assets 8,435 8,277
Amortization of debt issuance costs 362 305
Loss on early extinguishment of debt 52  
Share-based compensation expense 10,045 11,293
Loss on disposal of property and equipment 313 74
Impairment charges for property, equipment, and lease right-of-use assets 1,350 1,340
Adjustment to expected credit losses 4,666 (279)
Deferred income taxes 668 1,372
Changes in operating assets and liabilities:    
Receivables (14,449) (35,556)
Inventories (27,736) (45,879)
Prepaid expenses and other current and noncurrent assets 5,958 (3,350)
Trade accounts payable (28,315) 6,499
Accrued expenses and other liabilities 12,807 (21,204)
Income taxes, net 11,648 14,670
Other, net 1,418 2,708
Net cash provided by operating activities 40,454 75,855
Investing Activities    
Purchases of property and equipment (44,071) (38,410)
Acquisition of Stuart Weitzman, net of cash received (108,858)  
Capitalized software (2,738) (1,918)
Net cash used for investing activities (155,667) (40,328)
Financing Activities    
Borrowings under revolving credit agreement 748,500 537,368
Repayments under revolving credit agreement (613,000) (480,868)
Debt issuance costs (2,920)  
Dividends paid (7,104) (7,342)
Acquisition of treasury stock (5,051) (65,039)
Issuance of common stock under share-based plans, net (3,575) (8,820)
Contributions by noncontrolling interests 2,650 1,500
Net cash provided by (used for) financing activities 119,500 (23,201)
Effect of exchange rate changes on cash and cash equivalents 40 1
Increase in cash and cash equivalents 4,327 12,327
Cash and cash equivalents at beginning of period 29,636 21,358
Cash and cash equivalents at end of period $ 33,963 $ 33,685